Complimentary Shipping on Orders Over $200

GLOW: BPC-157+TB-500+GHK-Cu 10/10/50mg | 70mg (Research Only)

$115.00

Contents: BPC-157 (10 mg) + TB-500 (10 mg) + GHK-Cu (50 mg)

Form: Lyophilized Powder
Purity: ≥ 99% USA Tested, Verified Purity (HPLC Tested)
Verification: Verifiable COA’s (Batch-Matched)

Emerging Research Evidence:

This tri-analyte blend is utilized in laboratory research to examine integrated tissue-refresh signaling, structural resilience, and extracellular matrix dynamics. Investigators study this combination to evaluate matrix remodeling markers, cellular turnover vigor, and microvascular signaling agility in regenerative research models. The formulation supports controlled investigation of multi-pathway signaling interactions and biological harmony under experimental conditions.

Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated

Batch-verified inventory. See 3rd Party COA.

In stock

Batch: GL70-25247

GLOW Overview

GLOW is a multi-component research formulation incorporating BPC-157, TB-500, and GHK-Cu, designed to support experimental evaluation of integrated tissue-refresh signaling. In laboratory models, researchers use this synergistic blend to study how distinct peptide mechanisms interact to influence cellular turnover vigor, cytoprotection markers, and comprehensive matrix remodeling.

Scientific investigation focuses on total-pathway coordination related to connective tissue structure, angiogenic signaling agility, and systemic response modulation. By combining peptides with complementary profiles, this formulation allows researchers to observe complex biological interactions relevant to dermal resilience and structural adaptation in preclinical environments.

Current studies utilize GLOW to map the interconnected signaling networks that govern tissue integrity. This multi-peptide tool provides a robust framework for investigating how tri-pathway coordination supports biological harmony, offering a deeper look at molecular revitalization without focusing on clinical recovery or rejuvenation outcomes.


GLOW Structure

1) BPC-157 (15-aa Body Protection Compound fragment)

  • CAS Number: 137525-51-0
  • Molecular Formula: C₆₂H₉₈N₁₆O₂₂
  • Molecular Weight: ~1419.5 g/mol
  • Parent Compound: Body Protection Compound (gastric-derived pentadecapeptide)
  • Monoisotopic Mass: ~1418.70 Da
  • Synonyms: BPC-157, PL-14736, gastric pentadecapeptide

Research Focus Areas:

  • Connective tissue signaling

  • Cytoprotection pathways

  • Inflammatory response modulation


2) TB-500 (Thymosin β4 fragment 17–23)

  • CAS Number: 885340-08-9
  • Molecular Formula: C₃₈H₅₆N₁₀O₁₄
  • Molecular Weight: ~889.02 g/mol
  • Parent Compound: Thymosin β4 (full-length peptide)
  • Monoisotopic Mass: ~888.49 Da
  • Synonyms: TB-500, thymosin β4 fragment, Ac-LKKTETQ

Research Focus Areas:

  • Actin-binding and cellular migration

  • Angiogenic signaling markers

  • Soft-tissue structural models


3) GHK-Cu (Copper tripeptide complex)

  • CAS Number: 49557-75-7
  • Molecular Formula: C₁₄H₂₄CuN₆O₄
  • Molecular Weight: ~403.9 g/mol
  • Parent Compound: Gly-His-Lys copper complex
  • Monoisotopic Mass: ~403.12 Da
  • Synonyms: Copper tripeptide-1 (INCI), Cu-GHK

Research Focus Areas:

  • Collagen synthesis signaling

  • Dermal and extracellular matrix research

  • Vascular and cellular communication models


Blend Research Areas

  • Systemic tissue signaling models

  • Extracellular matrix remodeling

  • Inflammatory pathway regulation

  • Musculoskeletal and connective tissue research

  • Angiogenic and vascular signaling studies

  • Gene expression markers related to structural integrity


Condensed Research Summary

GLOW is a multi-component research blend utilized in laboratory settings to study integrated tissue-refresh signaling and synergistic structural resilience. Researchers focus on how coordinated peptide mechanisms influence matrix remodeling markers, angiogenic signaling agility, and cellular turnover vigor within experimental models. These exploratory studies map the timing of multi-pathway interactions, providing technical data on how combined signals support biological harmony without any focus on clinical recovery or rejuvenation outcomes.


Research-only note: GLOW is not FDA-approved for therapeutic use. Published effects are preclinical and exploratory. For laboratory research purposes only.

Disclaimer — For Research Purposes Only​

For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.

I am 21 years or older and understand that the products listed on this site are for research purposes only.